SCHEMBL533009

SCHEMBL533009

Cc1cc(C)c(N2CCCC2)c(C)c1NC(=O)c1cccc(C)c1-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
MAPT P10636 5/20 0.44
GAA P10253 4/20 0.44
L3MBTL1 Q9Y468 4/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
MAPK1 P28482 3/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
ATM Q13315 1/20 0.44
POLB P06746 2/20 0.42
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
BRPF1 P55201 1/20 0.41
PTGER4 P35408 2/20 0.39
FABP4 P15090 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL533064 0.87 MAPT (0.56) ALDH1A1MAPTGAAL3MBTL1SMN1; SMN2
SCHEMBL532826 0.87 ALDH1A1 (0.47) ALDH1A1MAPTGAAL3MBTL1SMN1; SMN2
SCHEMBL532983 0.86 MAPT (0.46) ALDH1A1MAPTGAAL3MBTL1SMN1; SMN2
SCHEMBL532809 0.86 ALDH1A1 (0.46) ALDH1A1MAPTGAAL3MBTL1SMN1; SMN2
SCHEMBL534076 0.85 POLB (0.53) ALDH1A1MAPTGAAL3MBTL1SMN1; SMN2
SCHEMBL532964 0.84 L3MBTL1 (0.47) ALDH1A1MAPTGAAL3MBTL1SMN1; SMN2
SCHEMBL533116 0.83 MAPT (0.46) ALDH1A1MAPTGAAL3MBTL1SMN1; SMN2
SCHEMBL533434 0.83 ALDH1A1 (0.44) ALDH1A1MAPTGAAL3MBTL1SMN1; SMN2
SCHEMBL8321708 0.83 ALDH1A1 (0.46) ALDH1A1MAPTGAAL3MBTL1SMN1; SMN2
SCHEMBL533536 0.83 L3MBTL1 (0.49) ALDH1A1MAPTGAAL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
WO-2004073634-A2 PHENYLENEDIAMINE UROTENSIN-II RECEPTOR ANTAGONISTS AND CCR-9 ANTAGONISTS ENCYSIVE PHARMACEUTICALS INC. (US) 2004-09-02 WO disclosed